Product Images Divalproex Sodium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Divalproex Sodium NDC 50090-7121 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This text appears to be a figure showing two studies (Study 1 and Study 2) comparing the effects of placebo (PBO) and divalproex sodium delayed-release tablets (DVPX) on some measure labeled as "YRS" or "WIRS". The "*" symbol with "p<0.05" possibly indicates a statistically significant difference between the two treatments. Additionally, it provides definitions of PBO (placebo) and DVPX (divalproex sodium delayed-release tablets).*
This text provides information about a comparison between Divalproex Sodium Delayed-Release Tablets and Placebo in reducing the number of Reduction in CPS (Central Processing Speed) Rats. The figure represents the percentage of patients showing improvement, no change, or worsening response.*
This text represents a chart showing the percentage of patients with different levels of improvement, no change, or worsening in CPS Rate. The chart is divided into High Dose and Low Dose categories.*
This text provides information on the mean 4-week Migraine Rates for Placebo and Divalproex Sodium delayed-release tablets in Study 1 and Study 2. It indicates that the mean dose of divalproex sodium delayed-release tablets was 1,087 mg/day, and the dose used in the studies ranged from 500 to 1,000 mg/day.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.